Skip to content

Author

V. Asati

We have 4 of 132 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Exploring the antidiabetic potential of DHA-salicylaldehyde-chalcone endowed 1,2,3-triazole hybrids: synthesis, α-glucosidase inhibition and molecular modeling studies.

AIM The present research work aims to synthesize and explore the in vitro α-glucosidase inhibition potentials of DHA-salicylaldehyde-chalcone endowed 1,2,3-triazoles to counter diabetes mellitus. MATERIALS AND METHODS A series of DHA-salicylaldehyde-chalcone endowed 1,2,3-triazole hybrids (4a-4l) was synthesized and...

Anshul Grover, V. Asati, Jayant Sindhu et al. · 0 citations
Review Aug 2026

Recent Updates on Novel Quinazoline‐Hybrid Molecules Possessing EGFR‐Mediated Anticancer Activity

As the first member of the receptor tyrosine kinase family, epidermal growth factor (EGFR) has been linked to human cancers through numerous lines of evidence. Research on EGFR has also led to the development of several key theories regarding cancer progression. Through a vast array of paracrine loops, each of which...

Ankur Vaidya, Shweta Jain, B. Kumar et al. · 0 citations
Review Open access Jul 2026

AI-driven computational drug design: tools, workflow and challenges

This review focuses on the AI-based approaches for target discovery, virtual screening, molecular generation, lead optimization, retro-synthesis, and structural modeling while also addressing issues of dataset bias, reproducibility, and real-world applicability.

Ryena Dhir, Pitam Ghosh, Dinki Sharma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.